NAMPT and periodontitis: In other studies, compared with before treatment, visfatin levels in saliva and GCF of patients with periodontitis significantly decreased (GCF, SMD: –3.04, 95% CI [−5.98 to −0.10]; Salivary, SMD: −1.64, 95% CI [−2.75 to −0.53]).